Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Contemporary Clinical Trials|August 28, 2020
Practical considerations of utilizing propensity score methods in clinical development using real-world and historical dataQing Li, Jianchang Lin, Andy Chi, et al.
Journal of Biopharmaceutical Statistics|November 29, 2024
DOD-BART: machine learning-based dose optimization design incorporating patient-level prognostic factors via Bayesian additive regression treesYunqi Zhao, Rachael Liu, Jianchang Lin, et al.
Journal of the American Podiatric Medical Association|July 25, 2012
Surgical reconstruction of severe forefoot derangement in a patient with traumatically acquired contralateral limb-length discrepancy: a case reportAlexander Bonner, Carlton C Cranford, Rakesh Patel, et al.
Ophthalmology|January 10, 2012
Eyes or subjects: are ophthalmic randomized controlled trials properly designed and analyzed?Chun Fan Lee, Andy Chi On Cheng, Daniel Yee Tak Fong
American Journal of Ophthalmology|November 12, 2013
Ophthalmic randomized controlled trials reports: the statement of the hypothesisChun Fan Lee, Andy Chi On Cheng, Daniel Yee Tak Fong
International Journal of Molecular Sciences|May 17, 2019
A Comprehensive Review on Current Advances in Peptide Drug Development and DesignAndy Chi-Lung Lee, Janelle Louise Harris, Kum Kum Khanna, et al.
Critical Reviews in Oncology/Hematology|January 27, 2016
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomasPier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, et al.
Critical Reviews in Oncology/Hematology|January 27, 2016
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomasPier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, et al.
Current Medical Research and Opinion|March 17, 2015
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous transplant: meta-analysis versus historical dataVijayveer Bonthapally, Eric Wu, Alexander Macalalad, et al.
Current Medical Research and Opinion|May 8, 2015
Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysisVijayveer Bonthapally, Hongbo Yang, Rajeev Ayyagari, et al.
Pageof 3